CN113509479B - 一种知母皂苷i在制备抗人卵巢癌药物中的应用 - Google Patents
一种知母皂苷i在制备抗人卵巢癌药物中的应用 Download PDFInfo
- Publication number
- CN113509479B CN113509479B CN202110858904.8A CN202110858904A CN113509479B CN 113509479 B CN113509479 B CN 113509479B CN 202110858904 A CN202110858904 A CN 202110858904A CN 113509479 B CN113509479 B CN 113509479B
- Authority
- CN
- China
- Prior art keywords
- timosaponin
- ovarian cancer
- human ovarian
- cells
- skov3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8964—Anemarrhena
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Reproductive Health (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gynecology & Obstetrics (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Pregnancy & Childbirth (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110858904.8A CN113509479B (zh) | 2021-07-28 | 2021-07-28 | 一种知母皂苷i在制备抗人卵巢癌药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110858904.8A CN113509479B (zh) | 2021-07-28 | 2021-07-28 | 一种知母皂苷i在制备抗人卵巢癌药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113509479A CN113509479A (zh) | 2021-10-19 |
CN113509479B true CN113509479B (zh) | 2022-01-28 |
Family
ID=78068804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110858904.8A Active CN113509479B (zh) | 2021-07-28 | 2021-07-28 | 一种知母皂苷i在制备抗人卵巢癌药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113509479B (zh) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012500776A (ja) * | 2008-04-11 | 2012-01-12 | バイオノボ・インコーポレーテッド | ハナスゲanemarrhenaasphodeloidesbungeの抽出物を使用する抗癌方法 |
CN103599122A (zh) * | 2013-11-29 | 2014-02-26 | 沈阳药科大学 | 知母中知母皂苷aⅲ在制备抗肿瘤药物的应用 |
CN105560261B (zh) * | 2015-12-31 | 2018-07-13 | 南京中医药大学 | 知母皂苷n在制备防治糖尿病药物中的应用 |
CN109053854B (zh) * | 2018-09-29 | 2021-05-14 | 深圳清博汇能医药科技有限公司 | 基于知母菝契皂苷元结构的衍生物、药物组合物及其应用 |
CN112114056A (zh) * | 2019-06-21 | 2020-12-22 | 好医生药业集团有限公司 | Uplc-ms法鉴定桂枝芍药知母汤中主要有效成分 |
-
2021
- 2021-07-28 CN CN202110858904.8A patent/CN113509479B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN113509479A (zh) | 2021-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zhao et al. | A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway | |
Min et al. | Astragaloside IV inhibits the progression of liver cancer by modulating macrophage polarization through the TLR4/NF-κB/STAT3 signaling pathway | |
Liu et al. | Low-dose naltrexone inhibits the epithelial-mesenchymal transition of cervical cancer cells in vitro and effects indirectly on tumor-associated macrophages in vivo | |
CN114480657A (zh) | 一种卵巢癌的标志物及其应用 | |
Yang et al. | Preliminary results indicate increased expression of miR-184 in patients with renal carcinoma. | |
CN113509479B (zh) | 一种知母皂苷i在制备抗人卵巢癌药物中的应用 | |
Shan et al. | Inonotsutriol E from Inonotus obliquus exhibits promising anti breast cancer activity via regulating the JAK2/STAT3 signaling pathway | |
CN113230251A (zh) | 阿苯达唑和多发性骨髓瘤临床药物的组合物及用途 | |
Fan et al. | Pedunculoside inhibits epithelial-mesenchymal transition and overcomes Gefitinib-resistant non-small cell lung cancer through regulating MAPK and Nrf2 pathways | |
Tao et al. | Activated pancreatic stellate cells enhance the warburg effect to cause the malignant development in chronic pancreatitis | |
Chen et al. | Brusatol suppresses the growth of intrahepatic cholangiocarcinoma by PI3K/Akt pathway | |
CN112410429B (zh) | Fxyd3作为胃癌诊断标志物和治疗靶标的应用 | |
Yang et al. | Decreasing expression of Prohibitin-2 lowers the oncogenicity of renal cell carcinoma cells by suppressing eIF4E-mediated oncogene translation via MNK inhibition | |
CN109731004B (zh) | 西维斯多在治疗结直肠癌方面的应用 | |
WO2017020752A1 (zh) | 抗胰腺癌单克隆抗体及其应用 | |
Wang et al. | Icaritin inhibits endometrial carcinoma cells by suppressing O-GlcNAcylation of FOXC1 | |
Yang et al. | p-Coumaric Acid Inhibits Osteosarcoma Growth by Inhibiting PI3K/Akt Signaling Pathway | |
CN112980948A (zh) | Nfat3作为治疗靶点在筛选或制备头颈部鳞状细胞癌药物中的应用 | |
CN111560433A (zh) | 人nufip1的用途及相关产品 | |
CN111521788B (zh) | Ptpmt1在作为肺癌诊断标志物和/或治疗靶点中的应用 | |
CN114164270B (zh) | Crip2在检测前列腺癌对多西他赛耐药性及逆转前列腺癌对多西他赛耐药性中的应用 | |
CN115025226B (zh) | Ptges表达抑制剂在制备提升肿瘤细胞对化疗药物的敏感性的药物中的应用 | |
CN114773304B (zh) | 一种从银线草提取物中分离得到的乌药烷型倍半萜化合物及其在制备治疗肝癌药物中的应用 | |
Liu et al. | Dual Blockage of P-cadherin and C-met Synergistically Inhibits the Growth of Head and Neck Cancer | |
CN117883420A (zh) | 一种小叶中国蕨提取物的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Liu Chen Inventor after: Deng Simin Inventor after: Xu Yuan Inventor after: Gao Binbin Inventor after: Zhang Jingyi Inventor after: Yu Tingting Inventor after: Yue Shen Inventor after: Cheng Yan Inventor before: Deng Simin Inventor before: Liu Chen Inventor before: Xu Yuan Inventor before: Gao Binbin Inventor before: Zhang Jingyi Inventor before: Yu Tingting Inventor before: Yue Shen Inventor before: Cheng Yan |